Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07430722 · ClinicalTrials.gov registry record

Cross-sectional Study of Vitamin B6 in Parkinson's Disease

A clinical trial, sponsored by University of Rochester.

Completed
Registry status
288
Enrollment target

NCT07430722 is a clinical trial that has completed, run by University of Rochester. The registered enrollment target is 288 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07430722 has completed, sponsored by University of Rochester.

COMPLETED
Registry status
288 participants
Enrollment target

Study Summary

The purpose of this study is to estimate the prevalence of abnormal serum levels of vitamin B6, and the associations of those levels with demographic and clinical variables in a randomly selected sample of people living with Parkinson's disease, compared to historical controls.

Trial Details

FieldValue
Enrollment Target 288 participants
Start Date 2024-07-01
Est. Completion 2026-02-15

Sponsor

University of Rochester

636 total trials

What the Registry Record Tells You About NCT07430722

The ClinicalTrials.gov registry entry for NCT07430722 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 288 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT07430722 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07430722 about?

NCT07430722 is a clinical study titled "Cross-sectional Study of Vitamin B6 in Parkinson's Disease". The purpose of this study is to estimate the prevalence of abnormal serum levels of vitamin B6, and the associations of those levels with demographic and clinical variables in a randomly selected sample of people living with Parkinson's disease, compared to historical controls.

What is the current status of trial NCT07430722?

This trial is currently completed. The enrollment target is 288 participants. The study started on 2024-07-01. Estimated completion is 2026-02-15.

Who is sponsoring clinical trial NCT07430722?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.